Last reviewed · How we verify
NCT03149692
Penile Transplant Study
NA trial testing Penile allograft transplantation in Penile Amputation in 2 participants. Completed in 11 December 2020.
11 December 2019
Quick facts
| Lead sponsor | University of Stellenbosch |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 2 |
| Start date | 11 November 2011 |
| Primary completion | 11 December 2019 |
| Estimated completion | 11 December 2020 |
| Sites | 1 location across South Africa |
Drugs / interventions tested
- Penile allograft transplantation
Conditions studied
- Penile Amputation — all drugs for Penile Amputation →
Sponsor
University of Stellenbosch
Who can join
Adults 18 to 40, male only, with Penile Amputation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
One case of unsuccessful penile transplantation has been reported from China. The patient had suffered an industrial machine accident and lost his penis to the level of the pubic skin. Unfortunately the patient's wife insisted at about two weeks post-operatively that the organ be removed. At the time of surgical removal the penis was viable, except for a degree of superficial skin necrolysis. This has sparked debate on ethical issues regarding penile transplantation. South Africa is uniquely positioned in Sub-Saharan Africa and worldwide with relatively advanced medical services and a high prevalence of ritual circumcision practice with reports of high morbidity and mortality in the last 20 years. The substantial number of young men left with a severe penile defect or complete loss of the penis \[9\] creates a possible place for penile allograft transplantation as a treatment option.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Living with someone else's penis: The lived experiences of two South African penile allograft recipients: A descriptive phenomenological study.
van der Merwe A, Toefy Y, Moosa MR, van Deventer H, et al · · 2021 · cited 7× · PMID 34527236 · DOI 10.1016/j.amsu.2021.102794
Verify or expand the search:
- PubMed search for NCT03149692
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Stellenbosch trials
Trials by the same sponsor.
- NCT06370923 — Harnessing Male Peer Networks to Enhance Engagement With HIV Prevention · NA · recruiting
- NCT05571319 — A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome. · Phase 2 · completed
- NCT05063240 — Mobile Phone Text Messaging Plus Motivational Interviewing: Effects on Breastfeeding, Child Health Outcomes · NA · unknown
- NCT06796413 — Loop Resection or Cold-cup Biopsy? A Study Comparing the Accuracy of Muscle Samples During Bladder Tumor Surgery · NA · completed
- NCT04099108 — Effect of Combined IV Bolus Amino Acid Supplementation and Mobilisation on Skeletal Muscle During the First 10 Days in t · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03149692 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Stellenbosch
- Last refreshed: 6 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03149692.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing